Discover 1,134 paid clinical trials in Bridgeport, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,134
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome,
Location: New Haven CT, Commack NY, Harrison NY, Uniondale NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06484062
Phase 1, Recruiting
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
for
Pulmonary Invasive Fungal Infections,
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 21
Code: NCT03827694
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: New Haven CT, Valhalla NY, New Hyde Park NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase 2, Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
for
Prostate Cancer
Location: New Haven CT, Commack NY, Harrison NY, Uniondale NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Male
Age: 18+
Code: NCT06457919
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
for
HPV Infection, HPV 16 Infection, High Risk HPV,
Location: New Haven CT, Akron OH, Minneapolis MN
Sponsor: Qurasense
Sex: Female
Age: 25+
Code: NCT07281599
Recruiting
Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
for
Diabetes, Type 2 Diabetes,
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06658067
Recruiting
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
for
Rotator Cuff Tears
Location: New Haven CT
Sponsor: CONMED Corporation
Sex: All
Age: 40 - 70
Code: NCT05997381
Recruiting
BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures
for
ACL Tears
Location: New Haven CT
Sponsor: CONMED Corporation
Sex: All
Age: 14 - 70
Code: NCT06948591
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: New Haven CT, New York NY, Worcester MA,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
for
Non Small Cell Lung Cancer
Location: Stony Brook NY, Stamford CT, White Plains NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312137
Phase 3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Stony Brook NY, Mineola NY, New Hyde Park NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase 2, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Stony Brook NY, Stamford CT, White Plains NY,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Stony Brook NY, The Bronx NY, New York NY, Hartford CT,
Sponsor: Children's Oncology Group
Sex: Female
Age: 0 - 39
Code: NCT06513962
Phase 3, Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
for
Episodic Migraine
Location: Stamford CT, Norfolk VA, Ajax, London, Akron OH,
Sponsor: H. Lundbeck A/S
Sex: All
Age: 6 - 17
Code: NCT05897320
Phase 3, Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
for
Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies,
Location: Stamford CT, Foxborough MA, Plymouth MA, Fairfax VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55 - 70+
Code: NCT07589595
Phase 2, Recruiting
A Study of Buntanetap in Participants With PD
for
Parkinson's Disease (PD), Deep Brain Stimulation
Location: Stamford CT, New York NY, Willow Grove PA,
Sponsor: Annovis Bio Inc.
Sex: All
Age: 40 - 70+
Code: NCT07284784
Phase 2, Phase 3, Recruiting
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Stamford CT, Lebanon NH, Tampa FL, Miami FL, El Paso TX
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18+
Code: NCT06752356
Phase 3, Recruiting
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients